Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
Objectives. The primary aim of our study was to evaluate long-term efficacy of secukinumab (SCK) in patients with axial spondyloarthritis (axSpA); secondary aims were to evaluate drug retention rate and to identify differences in the clinical and laboratory assessment according to axSpA clinical fea...
Main Authors: | Stefano Gentileschi, Donato Rigante, Jurgen Sota, Giuseppe Lopalco, Maria Grazia Giannotta, Giacomo Emmi, Gerardo Di Scala, Florenzo Iannone, Claudia Fabiani, Bruno Frediani, Luca Cantarini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/6983272 |
Similar Items
-
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
by: Jürgen Braun, et al.
Published: (2021-08-01) -
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman
by: G. Lopalco, et al.
Published: (2015-06-01) -
Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease
by: Marco Cattalini, et al.
Published: (2015-01-01) -
Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
by: Sara Alonso, et al.
Published: (2021-05-01) -
Update on the Medical Management of Gastrointestinal Behçet’s Disease
by: Giuseppe Lopalco, et al.
Published: (2017-01-01)